中東およびアフリカの更年期障害治療市場 – 2030 年までの業界動向と予測

中東およびアフリカの更年期障害治療市場の分析と規模

更年期は、女性の人生で最も身体的に負担の大きい時期の 1 つであり、世界中の製薬会社が更年期とそれに伴う問題を治療する効果的な薬の開発に力を入れています。更年期障害の発症率は、年間約 5,000 万件と予想されています。更年期障害は、49 歳から 52 歳の女性に自然に起こります。世界保健機関 (WHO) は、サハラ以南アフリカの 60 歳以上の成人の割合が、2015 年の 4,600 万人から 2050 年までに 1 億 5,700 万人に増加すると予測しています。

データブリッジ市場調査は、2023年から2030年の予測期間における更年期障害治療市場の成長率を分析しています。更年期障害治療市場の予想CAGRは、上記の予測期間中に約5.8％になる傾向があります。市場価値は2022年に4億230万米ドルで、2030年までに6億3150万米ドルまで成長すると予想されています。市場価値、成長率、市場セグメント、地理的範囲、市場プレーヤー、市場シナリオなどの市場洞察に加えて、データブリッジ市場調査チームがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

中東およびアフリカの更年期障害治療市場の範囲とセグメンテーション

Market Definition

Menopause is a natural biological process that occurs because of the reduction of reproductive hormones. This marks the end of the menstrual cycle. It generally occurs in the age of late 40s or 50s. The menopause symptoms are different for every women. Every woman experiences these menopause symptoms in a different way. Estrogen levels decline throughout menopause. These signs and symptoms include night sweats, vaginal dryness, hot flashes, abnormal menstrual cycles, difficulty sleeping, mood swings, and others.

Middle East and Africa Menopausal Disorder Treatment Market Dynamics

Drivers

• Increasing Demand of Herbal Treatments

With each passing decade, women are inclining more towards herbal supplements as a part of their menopause treatment which is one of the market's most significant latest developments. As a result, numerous companies are responding to the market need by manufacturing latest products which contain menopause-relieving components. For instance, black cohosh and soy isoflavones are the two natural remedies that worked well for menopause. The prevalence of menopausal disorder among menopaused women was expected around 54.87% in the Middle East countries. Thus, this disorder demands a huge increase of treatment, increasing the market growth rapidly.

• Increased Incidence Rate of Menopause

The World Health Organization estimates a rise in the proportion of adults over age 60 years in sub-Saharan Africa from 46 million people in 2015 to 157 million by 2050. Likewise, sub-Saharan African women can expect an increased life expectancy at 76 years. The occurrence of women experiencing menopause, commonly between the ages of 45 and 55 years, will also markedly increase. Furthermore, the 2007 National Census estimated 9.7 million women aged 30 years or older with 2.1 million in the menopausal age range of 45 to 55 years in Ethiopia alone. Thus, this boosts the market growth.

 Opportunities

• Major Impact of Trending Lifestyle and Stress

In recent years, it has become positively important to provide women with much effective therapy for menopause symptoms because of the rise in the occurrence of physical and mental health issues among women. Factors such as migraine, anxiety, irritability, formication, fatigue, hot flashes, mood swings, and insomnia, contribute a lot to many companies to develop cutting-edge therapies to improve these symptoms. Huge growth in the menopause therapy industry is being aided by widespread investments in extended R&D initiatives to launch novel medications. This factor is helping the market growth in a great way.

• Increasing Demand of Hormone Therapy

Hormone therapy is anticipated to present high growth during the forecast period. The most effective and widely accepted method of treating menopausal heat flashes is estrogen medication, increasing market growth. Hormone therapy is extensively accepted for a long time due to its efficiency and improvement in women’s health. Therefore, this factor accelerates the growth of the market.

Restraints/Challenges

• Growing Underlying Disparities Between Genders

Numerous companies providing multiple treatments for menopause have struggled considerably due to the extensive existence of major gender-wise health disparities in many of the nations. Women in nations with limited awareness and income see no gains in their health due to the lack of adequate healthcare infrastructure. This acts as a major restriction for the market.  

• Side Effects of Hormone Therapy

As per the guidelines of FDA, there are several complications related with hormone therapy that carry various hazards, that includes the possibility of heart problems, stroke, blood clots, and breast cancer. Thus, it hampers the market growth.   

This menopausal disorder treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the menopausal disorder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Middle East and Africa Menopausal disorder Treatment Market

The menopausal disorder treatment market is segmented on the basis of stages, type, menopause symptoms, dosage form, route of administration, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Stages

• Menopause
• Postmenopause
• Perimenopause

Type

• Hormonal Therapy
• Non-Hormonal Therapy

Menopause Symptoms

• Vasomotor Symptoms
• Atrophic Vaginitis
• Osteoporosis
• Joint Pain
• Weight Gain
• Dyspareunia
• Depression
• Others

Dosage Form

• Tablet
• Cream

• Gels
• Rings/Insert
• Patch/Film
• Injection Shot
• Spray
• Others

Route of Administration

• Oral
• Vaginal
• Transdermal
• Parenteral

End User

• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Others

Distribution Channel

• Direct Tender
• Retail Sales
• Other

Middle East and Africa Menopausal Disorder Treatment Market Regional Analysis/Insights

The menopausal disorder treatment market is analyzed and market size insights and trends are provided by stages, type, menopause symptoms, dosage form, route of administration, end-user and distribution channel as referenced above.

The major countries covered in the menopausal disorder treatment market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

Saudi Arabia is leading the menopausal disorder treatment market due to the increase in prevalence of hormonal & reproductive disorders in among female. Furthermore, the country witnessed advanced medical environment, a life expectancy for people over 80 years that is actually more compared to other regions, and minimized heart attack and stroke death rates than those in similar countries. Thus, all these factors led to the market growth in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Middle East and Africa Menopausal Disorder Treatment Market Share Analysis

The menopausal disorder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to menopausal disorder treatment market

更年期障害治療市場で活動している主要企業は次のとおりです。

• F.ホフマン・ラ・ロシュ社（スイス）
• マイランNV（米国）
• テバ製薬工業株式会社（イスラエル）
• サノフィ（フランス）
• ファイザー社（米国）
• GSK plc（英国）
• ノバルティスAG（スイス）
• アストラゼネカ（英国）
• ジョンソン・エンド・ジョンソン プライベート・リミテッド（米国）
• メルク社（米国）
• イーライリリー・アンド・カンパニー（米国）
• アボット（米国）
• ノボ ノルディスク A/S (デンマーク)
• アッヴィ社（米国）
• ドクター・レディーズ・ラボラトリーズ社（インド）
• セラピューティクスMD社（米国）
• イプセンファーマ（フランス）
• ベシンヘルスケア（ベルギー）
• ミスラ製薬（ベルギー）
• Aché Laboratorios Farmacêuticos SA (ブラジル)
• セベラ製薬（米国）
• ファーベント・ファーマシューティカルズ社（米国）
• KaNDy Therapeutics（英国）
• ダッシェネイ USA (米国) 

SKU-56620